Motley Fool Asset Management LLC grew its stake in Veeva Systems Inc. (NYSE:VEEV – Free Report) by 35.1% in the 4th quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission. The firm owned 15,285 shares of the technology company’s stock after buying an additional 3,971 shares during the period. Motley Fool Asset Management LLC’s holdings in Veeva Systems were worth $3,412,000 as of its most recent filing with the Securities and Exchange Commission.
Other institutional investors and hedge funds also recently made changes to their positions in the company. Raiffeisen Bank International AG bought a new stake in shares of Veeva Systems during the 3rd quarter valued at about $28,000. Board of the Pension Protection Fund bought a new stake in shares of Veeva Systems during the 4th quarter valued at about $27,000. Newbridge Financial Services Group Inc. boosted its position in shares of Veeva Systems by 322.6% during the 4th quarter. Newbridge Financial Services Group Inc. now owns 131 shares of the technology company’s stock valued at $29,000 after purchasing an additional 100 shares in the last quarter. Activest Wealth Management boosted its position in shares of Veeva Systems by 3,175.0% during the 4th quarter. Activest Wealth Management now owns 131 shares of the technology company’s stock valued at $29,000 after purchasing an additional 127 shares in the last quarter. Finally, BOK Financial Private Wealth Inc. bought a new stake in shares of Veeva Systems during the 4th quarter valued at about $33,000. Institutional investors and hedge funds own 88.20% of the company’s stock.
Analysts Set New Price Targets
VEEV has been the topic of several research analyst reports. Needham & Company LLC restated a “buy” rating and set a $270.00 target price on shares of Veeva Systems in a research report on Thursday, June 4th. Robert W. Baird upped their target price on Veeva Systems from $250.00 to $260.00 and gave the company an “outperform” rating in a research report on Thursday, June 4th. Mizuho cut their target price on Veeva Systems from $295.00 to $270.00 and set an “outperform” rating on the stock in a research report on Thursday, June 4th. Piper Sandler cut their target price on Veeva Systems from $285.00 to $235.00 and set an “overweight” rating on the stock in a research report on Thursday, June 4th. Finally, BNP Paribas Exane restated an “outperform” rating and set a $285.00 target price on shares of Veeva Systems in a research report on Thursday, June 4th. Eighteen equities research analysts have rated the stock with a Buy rating, eight have given a Hold rating and one has issued a Sell rating to the company’s stock. Based on data from MarketBeat, the company presently has an average rating of “Moderate Buy” and an average price target of $250.96.
Insider Transactions at Veeva Systems
In other Veeva Systems news, Director Priscilla Hung sold 750 shares of the stock in a transaction that occurred on Thursday, April 30th. The stock was sold at an average price of $155.64, for a total value of $116,730.00. Following the transaction, the director owned 3,253 shares in the company, valued at approximately $506,296.92. This represents a 18.74% decrease in their ownership of the stock. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is accessible through this hyperlink. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Insiders own 10.60% of the company’s stock.
More Veeva Systems News
Here are the key news stories impacting Veeva Systems this week:
- Positive Sentiment: UCB is unifying global safety operations on Veeva Safety Suite, a sign of continued customer adoption for Veeva’s regulated-industry software platform. UCB Unifies Global Pharmacovigilance Operations with Veeva Safety Suite
- Positive Sentiment: Analysts highlighted Veeva’s strong Q1, growing Vault CRM migrations, and AI expansion as reasons the stock may deserve a place in portfolios. Reasons to Add Veeva Systems Stock to Your Portfolio for Now
- Positive Sentiment: Management’s product push, including Falcon and Vault AI, is improving workflow automation across life sciences and supporting the long-term growth narrative. Veeva’s Falcon and Vault AI: When Could AI Become a Revenue Driver?
- Neutral Sentiment: Recent commentary from Veeva’s earnings call pointed to broad-based customer demand and stronger execution, but also said AI revenue is not expected to be a major contributor in fiscal 2027. The 5 Most Interesting Analyst Questions From Veeva Systems’s Q1 Earnings Call
- Negative Sentiment: Investors are also weighing concerns about saturation in the life sciences CRM market and the fact that AI monetization may take longer to show up in results. Reasons to Add Veeva Systems Stock to Your Portfolio for Now
Veeva Systems Stock Performance
Shares of NYSE:VEEV opened at $163.82 on Thursday. The business’s 50 day simple moving average is $165.61 and its two-hundred day simple moving average is $192.92. The firm has a market cap of $26.76 billion, a P/E ratio of 29.20, a PEG ratio of 0.73 and a beta of 0.95. Veeva Systems Inc. has a 52-week low of $148.05 and a 52-week high of $310.50.
Veeva Systems (NYSE:VEEV – Get Free Report) last announced its quarterly earnings results on Wednesday, June 3rd. The technology company reported $2.24 earnings per share (EPS) for the quarter, topping the consensus estimate of $2.14 by $0.10. The business had revenue of $882.95 million for the quarter, compared to analyst estimates of $857.73 million. Veeva Systems had a return on equity of 13.72% and a net margin of 28.37%.The company’s quarterly revenue was up 16.3% on a year-over-year basis. During the same quarter in the prior year, the company earned $1.97 earnings per share. Veeva Systems has set its FY 2027 guidance at 9.050-9.050 EPS and its Q2 2027 guidance at 2.210-2.220 EPS. On average, equities analysts forecast that Veeva Systems Inc. will post 6.55 earnings per share for the current fiscal year.
Veeva Systems Profile
Veeva Systems (NYSE: VEEV) is a cloud software company that develops industry-specific applications and data solutions for the global life sciences sector. Founded in 2007 and headquartered in Pleasanton, California, Veeva focuses on helping pharmaceutical, biotechnology, medical device and consumer health companies manage regulated content, clinical and regulatory processes, quality systems, and commercial operations in a compliant, cloud-native environment. The company completed its initial public offering in 2013 and has since expanded its product suite and international footprint.
Veeva’s product portfolio centers on its Vault platform and related application suites, which provide content and data management, clinical trial and regulatory workflows, quality management, and structured commercial capabilities such as customer relationship management and promotional content management.
Featured Stories
- Five stocks we like better than Veeva Systems
- Everpure: AI Storage Uncertainty Overshadows Breakneck Growth
- This Tech ETF Is Beating QQQ—and Canada May Be Part of the Reason
- Intel Is the Market’s Most Mispriced AI Hedge
- The Biggest Opportunity From SpaceX’s IPO May Surprise You
Want to see what other hedge funds are holding VEEV? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Veeva Systems Inc. (NYSE:VEEV – Free Report).
Receive News & Ratings for Veeva Systems Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Veeva Systems and related companies with MarketBeat.com's FREE daily email newsletter.
